Concert Pharmaceuticals, Inc.

Leading Indian companies such as Dr Reddy’s Laboratories, Sun Pharma and Cipla have deployed distinct strategic approaches to drive their business in China, a tough market to crack by any yardstick bu

Sun Pharmaceutical Industries Ltd. , is eying the partnering route as it seeks to advance into the high-profile glucagon-like peptide-1 (GLP-1) receptor agonist space, currently witnessing huge excite

China’s rise in just over a decade as a hotbed of pharma innovation, with pockets of excellence including in the high profile antibody drug conjugates (ADC) space, is a case study in itself. While Ind

Building out its specialty business in the US, at least for some key products, has been a David versus Goliath battle for Sun Pharmaceutical Industries Ltd. The Indian company has had to take on big